October 26, 2018, Cancer Research UK via Medical Xpress
A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new clinical trial results. The study, published in the New England Journal of Medicine, found that the drug olaparib (Lynparza) could delay the return of advanced ovarian cancer in some woman whose cancer cells carry a faulty BRCA gene, or stopped the disease from getting worse.
Read more.